Immutep
IMMP
9 hedge funds and large institutions have $72K invested in Immutep in 2014 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
29% more funds holding
Funds holding: 7 → 9 (+2)
26% more capital invested
Capital invested by funds: $57K → $72K (+$15K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$16.9K |
| 2 |
U
UBS
Zurich,
Switzerland
|
+$7.44K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$5.98K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.23K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$985 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$11K |
| 2 |
AG
Aperio Group
Sausalito,
California
|
-$8.96K |
| 3 |
Citigroup
New York
|
-$197 |
IMMP Hedge Fund Activity: Q2 2014 in Review
9 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Immutep (IMMP) for Q2 2014, worth a combined $72K — up 26% from $57K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new IMMP positions and 1 closed out — a net gain of 2 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $16.9K. The largest seller was Jane Street, exiting entirely with an estimated $11K sold.
- 9 institutional investors held Immutep (IMMP) as of Q2 2014, up from 7 in Q1 2014.
- Funds reported $72K of Immutep stock for Q2 2014, up 26% quarter-over-quarter.
- 3 funds opened new Immutep positions in Q2 2014 and 1 closed out, a net change of +2 holders.
- The largest Immutep buyer in Q2 2014 was Citadel Advisors, an estimated $16.9K added.
- The largest Immutep seller in Q2 2014 was Jane Street, an estimated $11K sold.
Based on aggregated 13F filings for Q2 2014.